Yen-Chieh Wang 1 2, Wei-Chi Ku 2, Chih-Yi Liu 2 3, Yu-Che Cheng 2 4 5, Chih-Cheng Chien 2 6, Kang-Wei Chang 7 8, Chi-Jung Huang 4 9
Affiliations
- Department of Urology, Cathay General Hospital, Taipei 106438, Taiwan.
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei 242062, Taiwan.
- Department of Pathology, Sijhih Cathay General Hospital, New Taipei 221037, Taiwan.
- Department of Medical Research, Cathay General Hospital, Taipei 106438, Taiwan.
- Department of Biomedical Sciences and Engineering, National Central University, Taoyuan 320317, Taiwan.
- Department of Anesthesiology, Cathay General Hospital, Taipei 106438, Taiwan.
- Taipei Neuroscience Institute, Taipei Medical University, Taipei 110301, Taiwan.
- Laboratory Animal Center, Taipei Medical University, Taipei 110301, Taiwan.
- Department of Biochemistry, National Defense Medical Center, Taipei 114201, Taiwan.
ABSTRACT
In bladder cancer, urothelial carcinoma is the most common histologic subtype, accounting for more than 90% of cases. Pathogenic effects due to the dysbiosis of gut microbiota are localized not only in the colon, but also in regulating bladder cancer distally. Butyrate, a short-chain fatty acid produced by gut microbial metabolism, is mainly studied in colon diseases. Therefore, the resolution of the anti-cancer effects of butyrate-producing microbes on bladder urothelial cells and knowledge of the butyrate-responsive molecules must have clinical significance. Here, we demonstrate a correlation between urothelial cancer of the bladder and Butyricicoccus pullicaecorum. This butyrate-producing microbe or their metabolite, butyrate, mediated anti-cancer effects on bladder urothelial cells by regulating cell cycle, cell growth, apoptosis, and gene expression. For example, a tumor suppressor against urothelial cancer of the bladder, bladder cancer-associated protein, was induced in butyrate-treated HT1376 cells, a human urinary bladder cancer cell line. In conclusion, urothelial cancer of the bladder is a significant health problem. To improve the health of bladder urothelial cells, supplementation of B. pullicaecorum may be necessary and can further regulate butyrate-responsive molecular signatures.
Keywords: Butyricicoccus pullicaecorum; apoptosis; bladder cancer-associated protein; butyrate; urothelial bladder cancer.
>Diagnostics (Basel). 2021 Dec 4;11(12):2270. doi: 10.3390/diagnostics11122270.